n-acetylsphingosine and Breast Neoplasms
n-acetylsphingosine has been researched along with Breast Neoplasms in 10 studies
Research
Studies (10)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Blumenthal, R; Francella, N; Garg, H; Kang, JH; Marquez, VE; Sigano, DM | 1 |
| Ahn, EH; Chang, CC; Hsieh, CY; Schroeder, JJ; Sun, W; Yang, H | 1 |
| Deng, Z; Du, WW; Fang, L; Jeyapalan, Z; Seth, A; Shan, SW; Yang, BB; Yang, BL; Yee, AJ; Zhang, Y | 1 |
| Goodhew, KL; Holly, JM; Keith, AJ; Perks, CM; Savage, PB; Winters, ZE | 1 |
| Benedict, M; Dixit, VM; Jäättelä, M; Shayman, JA; Tewari, M | 1 |
| Gill, ZP; Holly, JM; Newcomb, PV; Perks, CM | 2 |
| Gill, ZP; Holly, JM; Maile, LA; Perks, CM | 1 |
| Deng, J; Hung, MC; Kloosterboer, F; Klostergaard, J; Levitt, ML; Liao, Y; Zhang, H | 1 |
| Clarke, JB; Clemmons, DR; Holly, JM; McCaig, C; Perks, CM | 1 |
Other Studies
10 other study(ies) available for n-acetylsphingosine and Breast Neoplasms
| Article | Year |
|---|---|
Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Ceramides; Humans; Molecular Structure; Signal Transduction; Sphingolipids; Structure-Activity Relationship; T-Lymphocytes | 2009 |
Evaluation of chemotherapeutic and cancer-protective properties of sphingosine and C2-ceramide in a human breast stem cell derived carcinogenesis model.
Topics: Breast; Breast Neoplasms; Carcinogenesis; Cell Differentiation; Cell Transformation, Neoplastic; Epithelial Cells; Female; Humans; MCF-7 Cells; Neoplastic Stem Cells; Sphingosine; Stem Cells | 2019 |
Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.
Topics: Animals; Anthracenes; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Green Fluorescent Proteins; Humans; Mice; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sphingosine; Taxoids; Tyrphostins; Versicans | 2011 |
Prolactin acts as a potent survival factor for human breast cancer cell lines.
Topics: Apoptosis; Breast Neoplasms; Cell Survival; Combined Modality Therapy; Enzyme Inhibitors; Female; Humans; Prolactin; Sphingosine; Tumor Cells, Cultured | 2004 |
Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells.
Topics: Antigens, Surface; Apoptosis; Base Sequence; bcl-X Protein; Breast Neoplasms; Cell Division; Ceramides; Dexamethasone; Drug Resistance; Enzyme Activation; fas Receptor; Female; Humans; Luciferases; Molecular Sequence Data; NF-kappa B; Phospholipases A; Phospholipases A2; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Quinacrine; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingosine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1995 |
Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner.
Topics: Apoptosis; Breast Neoplasms; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Signal Transduction; Sphingosine; Tumor Cells, Cultured | 1997 |
Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cyclin A; Cyclin B; Cyclin B1; Female; Humans; Insulin-Like Growth Factor I; Kinetics; Oligopeptides; Recombinant Proteins; S Phase; Signal Transduction; Sphingosine; Tumor Cells, Cultured | 1999 |
The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells.
Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma; Cell Membrane; DNA Fragmentation; Drug Synergism; Epithelial Cells; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Peptide Hydrolases; Recombinant Proteins; Serine Proteinase Inhibitors; Somatomedins; Sphingosine; Sulfones; Tumor Cells, Cultured | 1999 |
Ceramide does not act as a general second messenger for ultraviolet-induced apoptosis.
Topics: Adenovirus E1A Proteins; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Breast Neoplasms; Caspase 1; Caspase 3; Caspase Inhibitors; Caspases; Ceramides; Enzyme Inhibitors; Female; Humans; Melanoma, Experimental; Mice; Protein Structure, Tertiary; Radiation Tolerance; Recombinant Fusion Proteins; Second Messenger Systems; Sphingosine; Transfection; Tumor Cells, Cultured; Ultraviolet Rays | 2002 |
Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Division; Cell Line; Dose-Response Relationship, Drug; Female; Humans; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Mutation; Somatomedins; Sphingosine; Tumor Cells, Cultured | 2002 |